Freestone Capital Holdings, LLC
- SEC CIK
- 0001470876
- Latest filing
- Jul 31, 2026
AVXL holding history
Anavex Life Sciences Corp. in every 13F filed by Freestone Capital Holdings, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVXL overviewAll 13F holders of AVXLFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −20,000−100.0% | Sold out | Holders |
| Q3 2025 | 20,000 | $178.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 20,000 | $184.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 20,000 | $171.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 20,000 | $214.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 20,000 | $113.6K | <0.1% | +6,200+44.9% | Added | Holders |
| Q2 2024 | 13,800 | $58.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 13,800 | $70.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 13,800 | $128.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 13,800 | $90.4K | <0.1% | +3,800+38.0% | Added | Holders |
| Q2 2023 | 10,000 | $81.3K | <0.1% | +10,000 | New | Holders |